See more : The Sustainable Nutrition Group Ltd (TSN.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Pharmaids Pharmaceuticals Limited (PHARMAID.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pharmaids Pharmaceuticals Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Confidence Petroleum India Limited (CONFIPET.BO) Income Statement Analysis – Financial Results
- Opter AB (publ) (OPTER.ST) Income Statement Analysis – Financial Results
- Rechi Precision Co., Ltd. (4532.TW) Income Statement Analysis – Financial Results
- Far East Consortium International Limited (FRTCF) Income Statement Analysis – Financial Results
- Protagenic Therapeutics, Inc. (PTIXW) Income Statement Analysis – Financial Results
Pharmaids Pharmaceuticals Limited (PHARMAID.BO)
Industry: Medical - Pharmaceuticals
Sector: Healthcare
About Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Ltd. engages in the development, formulation, manufacture, and distribution of drugs. It manufactures generics, bulk drugs and intermediaries. The company was founded on March 1, 1989 and is headquartered in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 145.97M | 0.00 | 39.39M | 85.51M | 0.00 | 5.61M | 4.49M | 12.03M | 16.84M | 17.30M | 14.05M | 12.75M | 12.35M | 7.84M | 5.10M | 4.21M | 4.66M |
| Cost of Revenue | 223.94M | 8.88M | 35.72M | 81.59M | 388.02K | 3.56M | 5.00M | 6.75M | 12.14M | 10.47M | 9.84M | 8.54M | 7.94M | 6.46M | 4.67M | 3.79M | 3.97M |
| Gross Profit | -77.97M | -8.88M | 3.68M | 3.92M | -388.02K | 2.05M | -510.70K | 5.27M | 4.71M | 6.83M | 4.21M | 4.20M | 4.42M | 1.38M | 434.00K | 420.00K | 689.00K |
| Gross Profit Ratio | -53.41% | 0.00% | 9.34% | 4.58% | 0.00% | 36.52% | -11.37% | 43.86% | 27.96% | 39.48% | 29.97% | 32.99% | 35.76% | 17.66% | 8.51% | 9.97% | 14.78% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 117.72K | 67.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 13.68M | 0.00 | 500.20K | 270.69K | 885.51K | 372.92K | 593.51K | 456.96K | 500.30K | 246.71K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 242.00K | 0.00 | 109.37K | 148.01K | 200.86K | 55.15K | 255.44K | 1.04M | 1.34M | 1.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 60.64M | 94.44M | 609.57K | 418.70K | 1.09M | 428.07K | 848.95K | 1.50M | 1.84M | 1.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 3.06M | -4.42M | 151.00K | 263.40K | -453.50K | 1.00K | -24.97K | 125.00 | 450.00K | 1.24M | 1.58M | 447.78K | 13.31K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 16.98M | 90.15M | 2.40M | 3.19M | 3.69M | 3.13M | 3.36M | 6.11M | 9.13M | 9.12M | 9.37M | 4.19M | 3.82M | 3.05M | 1.46M | 1.22M | 1.51M |
| Cost & Expenses | 298.06M | 99.03M | 38.11M | 84.78M | 3.69M | 6.69M | 8.36M | 12.86M | 21.26M | 19.59M | 19.22M | 12.73M | 11.76M | 9.51M | 6.13M | 5.01M | 5.48M |
| Interest Income | 2.16M | 0.00 | -2.00 | 0.00 | 0.00 | 51.43K | 200.72K | 100.57K | 6.72K | 4.00K | 8.71K | 2.89K | 2.69K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 15.78M | 46.00K | 27.00K | 42.00 | 8.40K | 169.00 | 14.04K | 385.45K | 212.78K | 36.00 | 67.39K | 60.38K | 45.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 17.25M | 167.95K | 92.00K | 448.26K | 388.02K | 458.46K | 10.89K | 637.09K | 1.04M | 1.37M | 800.58K | 734.34K | 757.89K | 771.00K | 771.00K | 384.00K | 813.00K |
| EBITDA | -123.54M | -98.88M | 1.37M | 1.33M | -3.36M | -965.13K | -3.66M | 1.86M | -3.00M | 326.08K | -2.78M | 745.42K | 1.35M | -896.00K | -258.00K | -417.00K | -9.00K |
| EBITDA Ratio | -84.63% | 0.00% | 3.86% | 1.69% | 0.00% | -10.24% | -81.82% | -0.97% | -17.81% | 1.80% | -19.87% | 5.85% | 10.94% | -11.43% | -5.06% | -9.90% | -0.19% |
| Operating Income | -140.06M | -99.03M | 1.28M | 732.00K | -3.69M | -1.48M | -3.87M | -4.07M | -4.49M | -1.06M | -3.59M | 11.09K | 593.13K | -1.67M | -1.03M | -801.00K | -822.00K |
| Operating Income Ratio | -95.95% | 0.00% | 3.25% | 0.86% | 0.00% | -26.30% | -86.22% | -33.86% | -26.66% | -6.13% | -25.57% | 0.09% | 4.80% | -21.27% | -20.17% | -19.01% | -17.64% |
| Total Other Income/Expenses | -16.16M | -33.00K | 123.74K | 152.35K | -58.40K | -350.96K | 186.67K | 1.66M | 98.47K | -36.00 | -67.39K | 379.00K | -365.95K | 0.00 | 0.00 | 0.00 | -343.00K |
| Income Before Tax | -156.21M | -99.08M | 1.40M | 884.35K | -3.75M | -1.43M | -3.69M | 824.73K | -4.32M | -1.06M | -3.66M | 390.08K | 227.19K | -1.67M | -1.03M | -801.00K | -1.17M |
| Income Before Tax Ratio | -107.02% | 0.00% | 3.56% | 1.03% | 0.00% | -25.49% | -82.06% | 6.86% | -25.65% | -6.13% | -26.05% | 3.06% | 1.84% | -21.27% | -20.17% | -19.01% | -24.99% |
| Income Tax Expense | -37.78M | -23.52M | -49.00K | -48.76K | -4.09M | 343.16K | 171.65K | -272.16K | -345.47K | -405.42K | -117.49K | -120.67K | -141.65K | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -79.68M | -75.56M | 1.45M | 933.11K | 335.34K | -1.77M | -3.86M | 1.10M | -3.98M | -655.06K | -3.54M | 510.75K | 368.83K | -1.67M | -1.03M | -801.00K | -1.17M |
| Net Income Ratio | -54.59% | 0.00% | 3.68% | 1.09% | 0.00% | -31.60% | -85.88% | 9.12% | -23.60% | -3.79% | -25.21% | 4.01% | 2.99% | -21.27% | -20.17% | -19.01% | -24.99% |
| EPS | -3.71 | -5.86 | 0.14 | 0.09 | 0.03 | -0.17 | -1.13 | 0.32 | -1.17 | -0.19 | -1.04 | 0.15 | 0.11 | -0.51 | -0.31 | -0.24 | 0.00 |
| EPS Diluted | -3.71 | -5.86 | 0.14 | 0.09 | 0.03 | -0.17 | -1.13 | 0.32 | -1.17 | -0.19 | -1.04 | 0.15 | 0.11 | -0.51 | -0.31 | -0.24 | 0.00 |
| Weighted Avg Shares Out | 21.49M | 12.90M | 10.31M | 10.31M | 10.31M | 10.31M | 3.41M | 3.41M | 3.41M | 3.41M | 3.41M | 3.41M | 3.41M | 3.27M | 3.32M | 3.34M | 0.00 |
| Weighted Avg Shares Out (Dil) | 21.49M | 12.90M | 10.31M | 10.31M | 10.31M | 10.31M | 3.41M | 3.41M | 3.41M | 3.41M | 3.41M | 3.41M | 3.41M | 3.27M | 3.32M | 3.34M | 0.00 |
No news found for: PHARMAID.BO
Source: https://incomestatements.info
Category: Stock Reports